Equity · Healthcare
OSCR
NYSEOscar Health (OSCR)
The line runs 29.62 USD on 12 August through 32.15 USD on 9 November, on a scale from 28 to 36. Days the market did not trade hold the previous close, flat.
- Market cap
- 10.9B USD
- P/E (TTM)
- 13.0
- Revenue, year to Dec 2025
- 28.6M USD
- EPS, diluted, year to Dec 2025
- −1.69 USD
- 52-week range
- 10.85 USD – 35.19 USD
- Avg volume
- 263.5K
- Mentions, 30 days
- 7
- Net sentiment
- +0.09
as of Nov 9, 2026
Have Oscar Health (OSCR) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, Oscar Health insiders reported 9 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 6 Apr 2026.
Form 4, 90 days to 11 Nov 2026, newest reported trade 18 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | WITTMAN VANESSA AMESDirector | Sell | 25,000 | 806K USD |
| 03 Sep 2026 | Baltrus VictoriaChief Accounting Officer | Sell | 958 | 30K USD |
| 03 Sep 2026 | Blackley Richard ScottChief Financial Officer | Sell | 28,869 | 908K USD |
| 03 Sep 2026 | Liang JanetPresident, Oscar Insurance | Sell | 10,360 | 326K USD |
| 03 Sep 2026 | McAnaney AdamChief Legal Officer | Sell | 9,092 | 286K USD |
| 03 Sep 2026 | Schlosser MarioDirector | Sell | 31,422 | 988K USD |
| 28 Aug 2026 | Schlosser MarioDirector | Sell | 150,000 | 4.6M USD |
| 27 Aug 2026 | Schlosser MarioDirector | Sell | 600,000 | 18.2M USD |
| 18 Aug 2026 | Blackley Richard ScottChief Financial Officer | Sell | 18,750 | 595K USD |
| Sold | 9 open-market sales | 874,451 | $26.76M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 18 Sep 2026 | Kushner JoshuaCo-Founder and Vice Chairman | Other | 19,030,851 | |
| 18 Sep 2026 | Thrive Partners II GP, LLCDirector | Other | 19,030,851 | |
| 28 Aug 2026 | Schlosser MarioDirector | Other | 150,000 | |
| 27 Aug 2026 | Schlosser MarioDirector | Other | 600,000 |
Which funds hold Oscar Health (OSCR)?
12 of the 45 institutional funds we track reported a Oscar Health position for the quarter ended 30 Jun 2026 — a combined 823.1M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Added | 12,643,617 | 360.6M USD | +130.5% |
| Citadel Advisors | Held (±25%) | 4,229,552 | 120.6M USD | +22.0% |
| Two Sigma Investments | Added | 4,035,689 | 115.1M USD | +71.8% |
| Renaissance Technologies | New position | 3,284,500 | 93.7M USD | |
| Tudor Investment Corp | Trimmed | 1,018,792 | 29.1M USD | −40.8% |
| Point72 Asset Management | Trimmed | 799,762 | 22.8M USD | −74.3% |
| Balyasny Asset Management | Added | 708,669 | 20.2M USD | +140.9% |
| Millennium Management | Added | 641,378 | 18.3M USD | +54.8% |
| Marshall Wace | Trimmed | 598,147 | 17.1M USD | −35.2% |
| AQR Capital Management | Added | 558,954 | 15.9M USD | +467.2% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
What has been filed or recorded for Oscar Health (OSCR)?
The filings we hold for Oscar Health, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 49 shares | 2K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 3 shares | 99 USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 207 shares | 7K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.49 USD | Revenue $5.14B |
| 30 Sep 2026 | Financials | Total assets | 10.0B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 2.2B USD | at period end |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 400 shares | 12K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 1.10 USD | Revenue $4.88B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 2.07 USD | Revenue $4.65B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.69 USD | Revenue $11.70B |
| 31 Dec 2025 | Financials | Revenue | 28.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −443.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.69 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.53 USD | Revenue $2.99B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.89 USD | Revenue $2.86B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.92 USD | Revenue $3.05B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.10 USD | Revenue $9.18B |
What is Reddit saying about Oscar Health (OSCR)?
Reddit mentioned OSCR 7 times in the 30 days to 10 November 2026, across 3 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Oscar Health (OSCR) compare with its price?
Share ↗
Is the Reddit crowd more bullish on Oscar Health than on the market?
OSCR reads 100% bullish, 47 points above the market (53%). Over 90 days the gap has run from -28 to +47 points.
- OSCR
- 100%
- bullish, 10 Nov
- Market
- 53%
- bullish, all Reddit, 10 Nov
- Gap
- +47 pts
- OSCR against market
Which subreddits are talking about Oscar Health (OSCR)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 57% | 4 | +0.10 |
| r/stocks | 29% | 2 | +0.08 |
| r/investing | 14% | 1 | +0.06 |
What do people ask about Oscar Health (OSCR)?
What did Oscar Health shares close at?32.15
Oscar Health closed at 32.15 USD on 9 Nov 2026, up 4.96% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Oscar Health’s market cap?10.9B
Oscar Health is worth 10.9B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Oscar Health’s P/E ratio?13.0
Oscar Health has a price-to-earnings ratio of 13.0, as of 9 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Oscar Health’s revenue?28.6M
Oscar Health reported revenue of 28.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Oscar Health insiders bought or sold shares recently?9 sales
In the 90 days to 11 Nov 2026, Oscar Health insiders reported 9 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 6 Apr 2026. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Oscar Health?12 of 45
12 of the 45 funds we track reported a Oscar Health position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Citadel Advisors and Two Sigma Investments. See Funds
When did Oscar Health last report earnings?0.49
Oscar Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.49 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Oscar Health?6 mentions
Oscar Health was mentioned 6 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of the 7 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings